The expression of integrin αvβ6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 751-755

  Mogi, Seiki ^a   Dang, Dongmin ^a   Van Waes, Carter ^c   Ellis, Duncan ^a   Atakilit, Amha ^a   Ramos, Daniel M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

v 6; Epithelial mesenchymal transition (EMT); Oral keratinocyte; Squamous cell carcinoma

Indexed keywords

ALPHAVBETA6 INTEGRIN; INTEGRIN; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; EVALUATION; FIBROBLAST; GROWTH INHIBITION; IMMUNOFLUORESCENCE MICROSCOPY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD29; ANTIGENS, NEOPLASM; CELL GROWTH PROCESSES; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FIBRONECTINS; FLOW CYTOMETRY; INTEGRIN BETA CHAINS; INTEGRINS; KERATINOCYTES; MALE; MESODERM; MICE; MICE, INBRED BALB C; MOUTH; VIMENTIN;

EID: 17444394015     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Silverman, S, Oral Cancer, 5th ed. B.C. Decker, Ontario, 2003.
2. Ramos DM, But M, Regezi J, Schmidt BL, Atakilit A, Dang D, Ellis D, Jordan R and Li X: Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol 21: 297-307, 2002.
3. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM and Marshall JF: αvβ6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol. 116(6): 898-904, 2001.
4. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 110(6): 673-687, 2002.
5. Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, SaIo T, Kramer R, Clark RA, Uitto VJ and Larjava H: Keratinocytes in human wounds express αvβ6 integrin. J Invest Dermatol 106(1): 42-48, 1996.
6. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D and Fogo AB: Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6 (-/-) mice. Am J Pathol 163(4): 1261-1273, 2003.
7. Hakkinen L, Koivisto L, Gardner H, Saarialho-Kere U, Carroll JM, Lakso M, Rauvala H, Laato M, Heino J and Larjava H: Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. Am J Pathol 164(1): 229-242, 2004.
8. Regezi JA, Ramos DM, Pytela R, Dekker NP and Jordan R: Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38(4): 332-326, 2002.
9. Thomas GR et al: Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral SCC. Int J Cancer 82: 377-384, 1999.
10. Crane JT et al: Transformation of oral keratinocytes in vitro by 4-nitroquinolone-N-oxide. Carcinogenesis 9: 2251-2256, 2000.
11. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37(1): 65-71, 2001.
12. Thomas GR, Chen Z, Enamorado I, Bancroft C and Van Waes C: IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma. Int J Cancer 86(3): 368-374, 2000.
13. Yang Y, Dang D, Atakilit A, Schmidt B, Regezi J. Li X, Eisele D, Ellis D and Ramos DM: Specific αv integrin receptors modulate K1735 murine melanoma cell behavior. Biochem. Biophys. Res. Commun. 308: 814-819, 2000.
14. Ramos DM, Chen B, Regezi J, Zardi L and Pytela R: Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 75: 680-687, 1998.
15. Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L and Pytela R: Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int J Cancer 72: 369-376, 1997.
16. Gasparoni A, Fonzi L, Schneider GB, Wertz PW, Johnson GK and Squier CA. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Oral Biol 49(8): 653-664, 2004.
17. Robinson CM, Stone AM, Shields JD, Huntley S, Paterson IC and Prime SS: Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Arch Oral Biol 48(11): 779-786, 2003.
18. Wang J, Lukse E, Seth A and McCulloch CA: Use of conditionally immortalized mouse cardiac fibroblasts to examine the effect of mechanical stretch on -smooth muscle actin. Tissue Cell 33(1): 86-96, 2001.
19. Russell RL, Cao D, Zhang D, Handschumacher RE and Pizzorno G: Uridine phosphorylase association with vimentin. Intracellular distribution and localization. J Biol Chem 276(16): 13302-13307, 2001.
20. Scott KA, Arnott CH, Robinson SC, Moore RJ, Thompson RG. Marshall JF and Balkwill FR: TNF-α regulates epithelial expression of MMP-9 and integrin during tumour promotion. A role for TNF-α in keratinocyte migration? Oncogene 23(41): 6954-6966, 2004.
21. Xue H, Atakilit A, Zhu W, Li X, Ramos DM and Pytela R: Role of the αvβ6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 288(3): 610-618, 2001.
22. Huang X, Wu J, Spong S and Sheppard D: The integrin is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci. 111(15): 2189-2195, 1998.